Klemens Budde

Chronic Rejection After Kidney Transplantation.

G. Böhmig, N. Kozakowski, Katharina A Mayer, 2024, Transplantation.

Long-Term Outcome after Early Mammalian Target of Rapamycin Inhibitor-Based Immunosuppression in Kidney Transplant Recipients

P. Glander, N. Lachmann, F. Friedersdorff, 2024, Journal of clinical medicine.

Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN).

D. Dragun, A. Loupy, M. Raynaud, 2024, Kidney international.

Continuous glucose monitoring (CGM) for the prediction of post-transplantation diabetes mellitus (PTDM) and impaired glucose tolerance (IGT) on day 90 after kidney transplantation – a prospective proof of concept study

M. Naik, E. Schrezenmeier, L. Liefeldt, 2024, American Journal of Transplantation.

Perspective for Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection After Kidney Transplantation: Defining Context of Use and Clinical Implications

E. Schütz, B. Osmanodja, Aylin Akifova, 2024, Transplant international : official journal of the European Society for Organ Transplantation.

De novo hemolytic uremic syndrome postrenal transplant after cytomegalovirus infection.

K. Budde, B. Rudolph, M. Ortner, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Deceased donor urinary DKK3 associates with future allograft function following kidney transplantation.

J. Stumpf, Elena Hantmann, Christoph Daniel, 2024, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

European Association of Urology Guidelines on Renal Transplantation: Update 2024.

R. Zakri, Ó. Faba, V. Hevia, 2024, European urology focus.

Kidney transplantation in patients with polycystic kidney disease: increased risk of infection does not compromise graft and patient survival

M. Naik, P. Glander, F. Friedersdorff, 2024, Clinical kidney journal.